Scientists create lab-grown brain tumor models to predict CAR T cell therapy effectiveness.

Researchers at the University of Pennsylvania have developed lab-grown organoids from patients' glioblastoma tumors to predict responses to CAR T cell therapy. These organoids accurately reflect how the actual tumors respond to treatment, allowing for personalized medicine and better understanding of potential neurotoxic side effects. This breakthrough could lead to more effective and safer treatments for this aggressive type of brain cancer.

3 months ago
6 Articles